Trump Medicaid drug pricing model 2026
One page that accretes the verified record as the story develops. Every fact keeps its date and its sources.
Opinion: Trump's free-riding targets for lowering drug prices are outside the U.S.
In Japan, roughly half of newly launched medicines are subject to annual price cuts.
American patients account for roughly three-quarters of pharmaceutical profits and over half of global research and development spending.
President Donald Trump secured nine new pricing agreements with drug manufacturers.
Trump to announce all 50 states joining Medicaid drug pricing model
JD Hayworth, a former Republican congressman and spokesperson for the Pharmaceutical Reform Alliance, said the announcement reflects meaningful progress but that progress remains incomplete.
The White House estimated in May that Trump's deals with pharmaceutical companies could save $529 billion over the next 10 years.
Experts say the savings from the Medicaid drug pricing model are unclear since the content of the deals is not public.